167 related articles for article (PubMed ID: 32443295)
1. NAD(P)H: quinone oxidoreductase 1 gene rs1800566 polymorphism increases the risk of cervical cancer in a Chinese Han sample: A STROBE-complaint case-control study.
Yang S; Zhao J; Li L
Medicine (Baltimore); 2020 May; 99(20):e19941. PubMed ID: 32443295
[TBL] [Abstract][Full Text] [Related]
2. The NQO1 rs1800566 polymorphism and risk of bladder cancer: evidence from 6,169 subjects.
Guo ZJ; Feng CL
Asian Pac J Cancer Prev; 2012; 13(12):6343-8. PubMed ID: 23464456
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphism 609C>T in NAD(P)H:quinone oxidoreductase 1 enhances the risk of proximal colon cancer.
Freriksen JJ; Salomon J; Roelofs HM; Te Morsche RH; van der Stappen JW; Dura P; Witteman BJ; Lacko M; Peters WH
J Hum Genet; 2014 Jul; 59(7):381-6. PubMed ID: 24830960
[TBL] [Abstract][Full Text] [Related]
4. NQO1 rs1800566 C>T polymorphism was associated with a decreased risk of esophageal cancer in a Chinese population.
Yin J; Wang L; Wang X; Zheng L; Shi Y; Shao A; Tang W; Ding G; Liu C; Liu R; Chen S; Gu H
Scand J Gastroenterol; 2014 Mar; 49(3):317-22. PubMed ID: 24354914
[TBL] [Abstract][Full Text] [Related]
5. Association between NAD(P)H:quinone oxidoreductase 1 rs1800566 polymorphism and risk of bladder cancer.
Zhang H; Wen X; Lu X; Zhang H
Tumour Biol; 2013 Dec; 34(6):3377-81. PubMed ID: 23873104
[TBL] [Abstract][Full Text] [Related]
6. "NQO1 Gene C609T Polymorphism (dbSNP: rs1800566) and Digestive Tract Cancer Risk: A Meta-Analysis.".
Yadav U; Kumar P; Rai V
Nutr Cancer; 2018; 70(4):557-568. PubMed ID: 29652514
[TBL] [Abstract][Full Text] [Related]
7. Association of NQO1 rs1800566 polymorphism and the risk of colorectal cancer: a meta-analysis.
Ding R; Lin S; Chen D
Int J Colorectal Dis; 2012 Jul; 27(7):885-92. PubMed ID: 22215148
[TBL] [Abstract][Full Text] [Related]
8. Genetic association of the NQO1 rs1800566 (609C>T) variant with risk of preeclampsia in the Chinese Han population.
Zhao L; Liu J; Tan P; Zhang W; Gao Q; Li X; Lin Y; Dong Q; Wang H; Liu S
Pregnancy Hypertens; 2017 Oct; 10():42-45. PubMed ID: 29153688
[TBL] [Abstract][Full Text] [Related]
9. Association of NQO1 levels and its genetic polymorphism with susceptibility to methamphetamine dependence.
Liu H; Zhang W; Deng XD; Ma Y; Liu Y
Mol Genet Genomic Med; 2021 Oct; 9(10):e1789. PubMed ID: 34467676
[TBL] [Abstract][Full Text] [Related]
10. Association of NAD (P) H Quinine Oxidoreductase 1 rs1800566 Polymorphism with Bladder and Prostate Cancers - a Systematic Review and Meta-Analysis.
Abedinzadeh M; Moghimi M; Dastgheib SA; Maleki H; Salehi E; Zare M; Jarahzadeh HM; Neamatzadeh H
Klin Onkol; 2020; 33(2):92-100. PubMed ID: 32303129
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in TP53 (rs1042522), p16 (rs11515 and rs3088440) and NQO1 (rs1800566) genes in Thai cervical cancer patients with HPV 16 infection.
Chansaenroj J; Theamboonlers A; Junyangdikul P; Swangvaree S; Karalak A; Chinchai T; Poovorawan Y
Asian Pac J Cancer Prev; 2013; 14(1):341-6. PubMed ID: 23534750
[TBL] [Abstract][Full Text] [Related]
12. Impact of VKORC1, CYP4F2 and NQO1 gene variants on warfarin dose requirement in Han Chinese patients with catheter ablation for atrial fibrillation.
Li J; Yang W; Xie Z; Yu K; Chen Y; Cui K
BMC Cardiovasc Disord; 2018 May; 18(1):96. PubMed ID: 29776386
[TBL] [Abstract][Full Text] [Related]
13. The NAD(P)H: quinine oxidoreductase 1 (NQO1) gene 609 C>T polymorphism is associated with gastric cancer risk: evidence from a case-control study and a meta-analysis.
Hu WG; Hu JJ; Cai W; Zheng MH; Zang L; Wang ZT; Zhu ZG
Asian Pac J Cancer Prev; 2014; 15(5):2363-7. PubMed ID: 24716985
[TBL] [Abstract][Full Text] [Related]
14. Clinical Significance of the NQO1 C609T Polymorphism in Non Small Cell Lung Adenocarcinoma Patients.
Masroor M; Jain A; Javid J; Mir R; Prashant Y; Imtiyaz A; Mariyam Z; Mohan A; Ray PC; Saxena A
Asian Pac J Cancer Prev; 2015; 16(17):7653-8. PubMed ID: 26625776
[TBL] [Abstract][Full Text] [Related]
15. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and lung cancer risk: a meta-analysis.
Lou Y; Li R; Xiong L; Gu A; Shi C; Chu T; Zhang X; Gu P; Zhong H; Wen S; Han B
Tumour Biol; 2013 Dec; 34(6):3967-79. PubMed ID: 23852860
[TBL] [Abstract][Full Text] [Related]
16. Association between NQO1 C609T polymorphism and colorectal cancer risk.
Wang Y; Zhang G; Luo Y
Tumour Biol; 2013 Dec; 34(6):4027-32. PubMed ID: 23893397
[TBL] [Abstract][Full Text] [Related]
17. Lack of association between NADPH quinone oxidoreductase 1 (NQO1) gene C609T polymorphism and lung cancer: a case-control study and a meta-analysis.
Guo S; Gao M; Li X; Li Y; Chu S; Zhu D; Niu W
PLoS One; 2012; 7(10):e47939. PubMed ID: 23110137
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of the NAD(P)H: quinine oxidoreductase 1 gene 609 C>T polymorphism with esophageal cancer risk.
Wang Z; Hu J; Zhong J
DNA Cell Biol; 2012 Apr; 31(4):560-7. PubMed ID: 22017531
[TBL] [Abstract][Full Text] [Related]
19. Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population.
Zhang J; Schulz WA; Li Y; Wang R; Zotz R; Wen D; Siegel D; Ross D; Gabbert HE; Sarbia M
Carcinogenesis; 2003 May; 24(5):905-9. PubMed ID: 12771035
[TBL] [Abstract][Full Text] [Related]
20. NAD(P)H:quinone oxidoreductase 1 (NQO1) P187S polymorphism and prostate cancer risk in Caucasians.
Stoehr CG; Nolte E; Wach S; Wieland WF; Hofstaedter F; Hartmann A; Stoehr R
Int J Mol Sci; 2012; 13(9):10959-10969. PubMed ID: 23109831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
